Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amoxicillin 250mg powder for solution for injection vials
0501013C0AAACAC
|
Amoxicillin sodium | Amoxicillin sodium | Infections | 6 |
|
Dalacin C 150mg capsules
0501060D0BBABAB
|
Dalacin C | Clindamycin hydrochloride | Infections | 6 |
|
Flucloxacillin 1g powder for solution for injection vials
0501012G0AAAEAE
|
Flucloxacillin sodium | Flucloxacillin sodium | Infections | 6 |
|
Metronidazole 100mg/5ml oral suspension
0501110C0AABTBT
|
Metronidazole (Systemic) | Metronidazole | Infections | 6 |
|
Pentamidine 300mg powder for solution for injection vials
0504080P0AAAAAA
|
Pentamidine isetionate | Pentamidine isetionate | Infections | 6 |
|
Quinine bisulfate 300mg/5ml oral suspension
0504010T0AAAFAF
|
Quinine bisulfate | Quinine bisulfate | Infections | 6 |
|
Triumeq 50mg/600mg/300mg tablets
050301000BBADA0
|
Proprietary compound preparation BNF 0503010 | Other HIV infection preparations | Infections | 6 |
|
Atripla 600mg/200mg/245mg tablets
0503010ANBBAAAA
|
Atripla | Efavirenz/emtricitabine/tenofovir disoproxil | Infections | 5 |
|
Co-amoxiclav 500mg/100mg inj vials
0501013K0AAAEAE
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 5 |
|
Colicym 1million unit pdr for neb soln unit dose vials
0501070I0BFAAAD
|
Colicym | Colistimethate sodium | Infections | 5 |
|
Dovato 50mg/300mg tablets
0503010AUBBAAAA
|
Dovato | Dolutegravir/lamivudine | Infections | 5 |
|
Granupas gastro-resistant granules 4g sachets
0501090A0BCAAAA
|
Granupas | Aminosalicylic acid | Infections | 5 |
|
Keflex 250mg capsules
0501021L0BCAAAA
|
Keflex | Cefalexin | Infections | 5 |
|
Posaconazole 40mg/ml oral suspension
0502010A0AAAAAA
|
Posaconazole | Posaconazole | Infections | 5 |
|
Sofosbuvir 400mg / Velpatasvir 100mg tablets
0503032J0AAAAAA
|
Sofosbuvir/velpatasvir | Sofosbuvir/velpatasvir | Infections | 5 |
|
Valganciclovir 50mg/ml oral solution sugar free
0503022B0AAADAD
|
Valganciclovir hydrochloride | Valganciclovir hydrochloride | Infections | 5 |
|
Viread 245mg tablets
0503010H0BBAAAA
|
Viread | Tenofovir disoproxil | Infections | 5 |
|
Wellvone 750mg/5ml oral suspension
0504080A0BBABAB
|
Wellvone | Atovaquone | Infections | 5 |
|
Amikacin 100mg/2ml solution for injection vials
0501040C0AAADAD
|
Amikacin (Parenteral) | Amikacin | Infections | 4 |
|
Baraclude 0.05mg/ml oral solution
0503031B0BBACAC
|
Baraclude | Entecavir | Infections | 4 |
|
Co-amoxiclav 1000mg/200mg inj vials
0501013K0AAAFAF
|
Co-amoxiclav | Co-amoxiclav (Amoxicillin/clavulanic acid) | Infections | 4 |
|
Diflucan 200mg capsules
0502010B0BBACAC
|
Diflucan | Fluconazole | Infections | 4 |
|
Diflucan 200mg/5ml oral suspension
0502010B0BBAHAH
|
Diflucan | Fluconazole | Infections | 4 |
|
Emtricitabine 200mg / Tenofovir alafenamide 25mg tablets
0503010AMAAABAB
|
Emtricitabine/tenofovir alafenamide | Emtricitabine and tenofovir alafenamide | Infections | 4 |
|
Fluconazole 200mg/100ml solution for infusion vials
0502010B0AAAEAE
|
Fluconazole | Fluconazole | Infections | 4 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.